Intracranial injections of bispecific EGFR- and EGFRvIII-directed CD28.CD3ζ.CAR-NK-92/NKL prolonged the survival of GBM xenograft mouse models and were characterized by increased cytotoxicity and IFN-γ secretion [99]. The gene discussed is CD28; the disease is glioblastoma.